Abstract

The field of nanotechnology in cancer includes the use of materials precisely constructed at the molecular level to develop devices and novel imaging and therapy techniques to improve the therapeutic ratio of cancer treatments. Recent advances in the application of nanotechnology to cancer hold a great promise to improve the detection, treatment, and prevention of cancer. In this scientific symposium, we will present a primer on the science of nanotechnology and discuss how it can be used to improve the imaging and treatment of cancer, including radiation therapy. We will describe the latest research and development in this exciting and rapidly advancing field. We will review newly developed cancer diagnostics and therapies, including the combination of imaging combined with drug delivery, based on nanotechnology and identify future directions.The specific objectives of the symposium are to:1. Provide a primer on nanotechnology in cancer and the science behind it.2. Describe the potential use of nanotechnology to improve the imaging of cancer and imaging combined with drug delivery.3. Describe the potential use of nanotechnology to improve the treatment of cancer, including radiation treatment.4. Describe the potential use of nanotechnology to deliver the treatment directly to the tumor while sparing healthy tissue, including radiation treatment.5. Describe promising newly developed cancer diagnostics and therapies based on nanotechnology, future directions, and the role medical physicists can play to advance the field.6. Describe the challenges of translating nanotechnology from the academic bench to the clinic.

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.